Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery (Drs Leboulanger, Garabedian, and Denoyelle), Radiology (Dr Garel), and Cardiology (Dr Borde), Armand Trousseau Children's Hospital, Paris, France.
Lingual localization of lymphangiomas presents a therapeutic challenge mostly because of the lesions' microcystic characteristics, which make complete surgical excision difficult if not impossible, and because of the functional problems they cause (obstruction, pain, feeding problems, edema, jaw deformities, breathing problems, and bleeding). Partial glossectomies have a high rate of relapse and can result in morphological changes in the tongue; sclerosing agents cannot be used on microcystic lesions. The use of several treatments aiming to resurface microcystic lymphatic lingual lesions with hemorrhagic vesicles, including laser and radiofrequency resurfacing (Coblation [cold plus ablation]; ArthroCare ENT, Austin, Texas), has been reported, sometimes with good results.1
Leboulanger N, Garel C, Borde IT, Garabedian E, Denoyelle F. Propranolol Therapy for Hemorrhagic Lymphangioma of the Tongue. Arch Otolaryngol Head Neck Surg. 2011;137(8):813–815. doi:10.1001/archoto.2011.70
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: